Xingmu is a Health Care startup founded in 2019. The company's slogan "Xingmu creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses" reflects its focus on developing advanced solutions in the field of gene editing and therapy for ocular diseases. The company recently secured Seed Round investment on 20 March 2024, with participation from Cowin Venture and Hefei Innovation Investment.
General Information
BounceWatch is an independent company data service, not affiliated with Xingmu. To contact Xingmu, visit starrygene.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Health Care
About Xingmu
Funding Rounds & Investors (2)
View AllXingmu Alternatives & Competitors
Fighting genetic illnesses with cutting-edge research and compassion
Pragmatic digital solutions for Cell and Gene Therapy Manufacturing
Pioneering advanced technologies and new treatments in gene therapy.
FAQ About Xingmu
Source: BounceWatch company record for Xingmu, https://bouncewatch.com/company/xingmu, updated 3 August 2024. When citing, please name BounceWatch and link this page.